Central Versus Peripheral Blood Pressure in Malignant Hypertension; Effects of Antihypertensive Treatment | Zendy

Bas van den Bogaard | Zendy; Rogier V. Immink | Zendy; Berend E. Westerhof | Zendy; Gert A. van Montfrans | Zendy; Johannes J. van Lieshout | Zendy; BertJan H. van den Born | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Central Versus Peripheral Blood Pressure in Malignant Hypertension; Effects of Antihypertensive Treatment

Author(s) -

Bas van den Bogaard,

Rogier V. Immink,

Berend E. Westerhof,

Gert A. van Montfrans,

Johannes J. van Lieshout,

BertJan H. van den Born

Publication year - 2013

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1093/ajh/hps075

Subject(s) - labetalol , medicine , blood pressure , sodium nitroprusside , pulse pressure , anesthesia , diastole , mean arterial pressure , hemodynamics , cardiology , heart rate , nitric oxide

Sodium nitroprusside (SNP) and labetalol are recommended for the immediate treatment of malignant hypertension. Both are intravenous agents but have different effects on systemic hemodynamics, and may have differential effects on pulse-wave reflection and pulse-pressure amplification, with consequences for peripheral versus central blood pressures (BPs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research